ENTRY       D10012                      Drug
NAME        Incobotulinumtoxin A (JAN/USAN);
            Onaclostox;
            Xeomin (TN)
PRODUCT     XEOMIN (Merz North America)
            XEOMIN (Merz Pharmaceuticals)
FORMULA     C2286H3500N578O666S9. C4422H6863N1151O1329S23
EXACT_MASS  148084.3667
MOL_WEIGHT  148175.5251
REMARK      Therapeutic category: 1229
            Product: D10012<JP/US>
EFFICACY    Skeletal muscle relaxant, SNAP25 protein inhibitor
  DISEASE   Cervical dystonia [DS:H01608]
COMMENT     Incobotulinumtoxin A is a botulinum toxin type A drug without complexing proteins.
            Treatment of spasticty, cervical dystonia, benign essential blepharospasm and glabellar lines
TARGET      SNAP25 [HSA:6616] [KO:K18211]
  PATHWAY   hsa04721(6616)  Synaptic vesicle cycle
INTERACTION  
BRITE       USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Dermatological Agents, Miscellaneous
                Incobotulinumtoxin A
                 D10012  Incobotulinumtoxin A (JAN/USAN)
             Skeletal Muscle Relaxants
              Incobotulinum Toxin A
               D10012  Incobotulinumtoxin A (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               122  Skeletal muscle relaxants
                1229  Others
                 D10012  Incobotulinumtoxin A (JAN/USAN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Nervous system
                SNAP25
                 D10012  Incobotulinumtoxin A (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10012
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10012
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10012
DBLINKS     CAS: 93384-43-1
            PubChem: 135626733
///
